Cargando…
Utility of IL-6 in the Diagnosis, Treatment and Prognosis of COVID-19 Patients: A Longitudinal Study
COVID-19 has caused devastating effects worldwide ever since its origin in December 2019. IL-6 is one of the chief markers used in the management of COVID-19. We conducted a longitudinal study to investigate the role of IL-6 in diagnosis, treatment, and prognosis of COVID-19-related cytokine storm....
Autores principales: | Jain, Vikram, Kumar, Pratap, Panda, Prasan Kumar, Suresh, Mohan, Kaushal, Karanvir, Mirza, Anissa A., Raina, Rohit, Saha, Sarama, Omar, Balram J., Subbiah, Vivekanandhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696839/ https://www.ncbi.nlm.nih.gov/pubmed/36366295 http://dx.doi.org/10.3390/vaccines10111786 |
Ejemplares similares
-
Correlation of serum SARS-CoV-2 IgM and IgG serology and clinical outcomes in COVID-19 patients: Experience from a tertiary care centre
por: Suresh, Mohan, et al.
Publicado: (2023) -
Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis
por: Kaushal, Karanvir, et al.
Publicado: (2022) -
Association of multidrug resistance behavior of clinical Pseudomonas aeruginosa to pigment coloration
por: Kothari, Ashish, et al.
Publicado: (2022) -
Genetic Variations in IL-1β, TNF-α, and TGF-β Associated with the Severity of Chronic Cervical Spondylitis in Patients
por: Yadav, Shashi Ranjan Mani, et al.
Publicado: (2023) -
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial
por: Panda, Prasan Kumar, et al.
Publicado: (2020)